Claims for Patent: 9,895,354

Summary for Patent: 9,895,354

Title:	Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities
Abstract:	The present invention provides for bilayered composites that provide for sustained drug delivery and support to recovering tissue(s) and areas surrounding, such as with bone tissue. The two layers degrade at separate rates, thereby providing sustained mechanical support and tailored drug delivery.
Inventor(s):	Puleo; David (Lexington, KY), Orellana; Bryan (Lexington, KY), McQuinn; Mike (Lexington, KY)
Assignee:	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (Lexington, KY)
Application Number:	14/678,457
Patent Claims:	1. A bilayered bone graft composite for bone augmentation comprising an outer shell layer comprised of a first bioceramic and an inner core layer comprised of a second bioceramic, wherein the first and second bioceramics are different such that one layer degrades in situ within a subject at a rate faster than the other layer to allow for cell infiltration in situ with the slower degrading layer preformed to mechanically support the bilayered bone graft composite and surrounding tissue in situ and further wherein the inner core layer is encased by the outer core layer. 2. The bilayered composite of claim 1, wherein the outer shell layer degrades faster than the inner core layer. 3. The bilayered composite of claim 1, wherein the inner core layer degrades faster than the outer shell layer. 4. The bilayered composite of claim 1, wherein one layer comprises a material selected from the group consisting of dicalcium phosphate dihydrate (DCPD), hydroxyapatite, calcium-deficient hydroxyapatite, carbonate-substituted hydroxyapatite, and calcium polyphosphate. 5. The bilayered composite of claim 4, wherein the other layer comprises a material selected from the group consisting of calcium sulfate (CS), .beta.-tricalcium phosphate, amorphous calcium phosphate, monetite, and tetracalcium phosphate. 6. The bilayered composite of claim 1, wherein one layer comprises calcium sulfate and the other layer comprises calcium phosphate. 7. The bilayered composite of claim 6, wherein the calcium phosphate is dicalcium phosphate dihydrate. 8. The bilayered composite of claim 1, wherein at least one layer further comprises a pharmaceutical agent selected from the group consisting of: simvastatin, lovastatin, rosuvastatin, bone morphogenetic proteins, human parathyroid hormone fragment 1-34, metronidazole, doxycycline, vancomycin, gentamycin, ciprofloxacin, ketoprofen, celecoxib, diclofenac, meloxicam or combinations thereof. 9. The bilayered composite of claim 8, wherein both layers further comprise a pharmaceutical agent. 10. The bilayered composite of claim 8, wherein the pharmaceutical agent is preloaded in a degradable matrix or a hydrogel. 11. The bilayered composite of claim 1, wherein the subject is an animal. 12. The bilayered composite of claim 1, wherein the subject is a human. 13. The bilayered composite of claim 1, wherein the outer layer further comprises polymer particles. 14. The bilayered composite of claim 1, wherein the inner layer further comprises polymer particles. 15. The bilayered composite of claim 1, wherein the inner layer and the outer layer form concentric cylinders. 16. A method of providing tissue support to a subject in need thereof, comprising administering the bilayered composite of claim 1 to tissue of the subject. 17. The method of claim 16, further comprising preloading one layer with a pharmaceutical agent. 18. The method of claim 17, wherein the pharmaceutical agent is in a degradable matrix or hydrogel within the layer. 19. The method of claim 16, wherein both layers further comprise preloading with a pharmaceutical agent. 20. The method of claim 16, wherein the tissue is osseous tissue.

Details for Patent 9,895,354

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2039-02-26